About Amy Bregar, MD

Amy Bregar, MD, was born in Pittsburgh, Pennsylvania and graduated from Princeton University. Dr. Bregar received her medical degree from the University of Pittsburgh School of Medicine. She completed a residency in obstetrics and gynecology at Brown University/Women and Infants Hospital and a fellowship in gynecologic oncology at Massachusetts General Hospital. Dr. Bregar is faculty at Massachusetts General Hospital and is the director of the Gynecologic Oncology program at Wentworth-Douglass Hospital in Dover, New Hampshire.

Dr. Bregar is an Assistant in Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is the director of the gynecologic oncology sub-internship for medical students and is lead faculty for the resident gynecologic oncology rotation at Massachusetts General Hospital. She has won numerous teaching awards from the Warren Alpert School of Medicine of Brown University and Harvard Medical School.

Dr. Bregar’s research interest include clinical trial development, medical education, and quality improvement. She is a member of multiple professional organizations, including the New Investigators Committee and the Older Adults Working Group of the national NRG (formally Gynecologic Oncology Group or GOG). Dr. Bregar is a principal investigator of clinical trials evaluating novel therapies in the treatment of ovarian cancer. Dr. Bregar has completed the Partner’s Clinical Process Improvement Leadership Program (CPIP) with the goal of reducing operating room turnover time.

Clinical Interests:

Treats:

Locations

Women's Cancer Center
55 Fruit Street
Boston, MA 02114-2696
617-724-4800
Fax: 617-724-6898

Medical Education

  • MD, University of Pittsburgh School of Medicine
  • Residency, Women and Infants Hospital/Brown University

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Publications

    1. Bregar A, Mojtahed A, Kilcoyne A, Kurra V, Melamed A, Growdon W, Rauh-Hain JA, del Carmen M, Lee SI. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy. Gynecol Oncol 2019. 152(3)568-573
    2. Bregar AJ, Cronin B, Luis C, DiSilvestro P, Schechter S, Pisharodi L, Raker C, Clark M, Robison K. Concomitant anal and cervical high-risk HPV genotyping in women with and without anogenital dysplasia or neoplasia. J Low Genit Tract Dis 2018. 22(2):115-119
    3. Bregar A, Deshpande A, Grange C, Zi T, Stall J, Hirsch H, Reeves J, Sathyanarayanan S, Growdon WB, Rueda BR. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors. Gynecol Oncol 2017. 145(3):446-452
    4. Bregar AJ, Melamed A, Diver E, Clemmer JT, Uppal S, Schorge JO, Rice LW, del Carmen MG, Rauh-Hain JA. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Database. Ann Surg Oncol 2017. 24(6):1677-1687